Sawsan Rashdan, M.D.

Sawsan Rashdan, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in treating thoracic malignancies. She is the Director of Thoracic Medical Oncology Clinical Operations.

Dr. Rashdan earned her medical degree at the Faculty of Medicine of Damascus University in Syria. She performed her residency in internal medicine at the Indiana University School of Medicine, where she also completed advanced fellowship training in hematology and oncology.

Certified by the American Board of Internal Medicine in hematology and medical oncology, she joined the UT Southwestern faculty in 2016.

Dr. Rashdan’s research focuses on lung cancer, and she has published a number of academic articles on the subject. She has received funding to pilot a clinical trial to investigate the role of stereotactic ablative radiotherapy (SABR) plus osimertinib as first-line treatment in epidermal growth factor receptor-mutated non-small cell lung cancer. Additionally, she is the Division Quality Officer as well as the Director of Health Equity in the division of hematology and oncology, leading the effort to reduce inequities of health care and increase access of cancer prevention education in minority groups.

Dr. Rashdan also spends time teaching the trainees at UTSW, she leads the lung cancer curriculum for the hematology and oncology fellows at Parkland. In addition to mentoring many fellows, residents, and medical students.

She is a member of several professional organizations, including the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, and the Dallas County Medical Society as well as American Muslim Women Physicians Association. She is also a member of several committees including: Supporting Women in Achieving Greatness, and Diversity, Equity and Inclusion committee in the Department of Internal Medicine at UTSW.

Medical School

Damascus University School of Medicine, Syria (2008)

Residency

Indiana University School of Medicine (2012), Internal Medicine

Fellowship

Indiana University School of Medicine (2016), Hematology Oncology

• Immunotherapy Treatment in Lung Cancer

Featured Publications

Going into BATTLE: umbrella and basket clinical trials to accelerate the study of biomarker-based therapies.

Rashdan S, Gerber DE Ann Transl Med 2016 Dec 4 24 529

Salvage Therapy for Patients With Germ Cell Tumor.

Rashdan S, Einhorn LH J Oncol Pract 2016 May 12 5 437-43

Cumulative effect of zinc oxide and titanium oxide nanoparticles on growth and chlorophyll a content of Picochlorum sp.

Hazeem LJ, Bououdina M, Rashdan S, Brunet L, Slomianny C, Boukherroub R Environ Sci Pollut Res Int 2016 Feb 23 3 2821-30

Effect of magnetic iron oxide (Fe3O4) nanoparticles on the growth and photosynthetic pigment content of Picochlorum sp.

Hazeem LJ, Waheed FA, Rashdan S, Bououdina M, Brunet L, Slomianny C, Boukherroub R, Elmeselmani WA Environ Sci Pollut Res Int 2015 Aug 22 15 11728-39

Nintedanib for the treatment of non-small-cell lung cancer.

Rashdan S, Hanna N Expert Opin Pharmacother 2014 Apr 15 5 729-39

Pyridyl thioureas as switchable anion receptors.

Rashdan S, Light ME, Kilburn JD Chem. Commun. (Camb.) 2006 Nov 44 4578-80

• Pilot and Feasibility Biomedical Research Award
  UT Southwestern Department of Internal Medicine (2017)
• Appreciation Award
  First Congress of Faculty of Medicine (2006)
• Certificate of Excellence
  Ministry of Higher Education for Research Efforts (2006)

• American Muslim Women Physicians Association
• American Society of Clinical Oncology
• Dallas County Medical Society
• International Association for the Study of Lung Cancer